These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16220971)

  • 1. Selective inhibition of MCF-7(piGST) breast tumors using glutathione transferase-derived 2-methylene-cycloalkenones.
    Joseph E; Ganem B; Eiseman JL; Creighton DJ
    J Med Chem; 2005 Oct; 48(21):6549-52. PubMed ID: 16220971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the glutathione transferase-catalyzed conversion of antitumor 2-crotonyloxymethyl-2-cycloalkenones to GSH adducts.
    Hamilton DS; Zhang X; Ding Z; Hubatsch I; Mannervik B; Houk KN; Ganem B; Creighton DJ
    J Am Chem Soc; 2003 Dec; 125(49):15049-58. PubMed ID: 14653739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.
    Srivastava SK; Singhal SS; Hu X; Awasthi YC; Zimniak P; Singh SV
    Arch Biochem Biophys; 1999 Jun; 366(1):89-94. PubMed ID: 10334868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.
    Morgan AS; Sanderson PE; Borch RF; Tew KD; Niitsu Y; Takayama T; Von Hoff DD; Izbicka E; Mangold G; Paul C; Broberg U; Mannervik B; Henner WD; Kauvar LM
    Cancer Res; 1998 Jun; 58(12):2568-75. PubMed ID: 9635580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil.
    Pandya U; Srivastava SK; Singhal SS; Pal A; Awasthi S; Zimniak P; Awasthi YC; Singh SV
    Biochem Biophys Res Commun; 2000 Nov; 278(1):258-62. PubMed ID: 11071881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the antitumor activities of 2-crotonyloxymethyl-2-cycloalkenones.
    Joseph E; Eiseman JL; Hamilton DS; Wang H; Tak H; Ding Z; Ganem B; Creighton DJ
    J Med Chem; 2003 Jan; 46(1):194-6. PubMed ID: 12502374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular response to a glutathione S-transferase P1-1 activated prodrug.
    Rosario LA; O'Brien ML; Henderson CJ; Wolf CR; Tew KD
    Mol Pharmacol; 2000 Jul; 58(1):167-74. PubMed ID: 10860939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells.
    Osbild S; Brault L; Battaglia E; Bagrel D
    Anticancer Res; 2006; 26(5A):3595-600. PubMed ID: 17094488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
    Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH
    Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic selectivity and solubility--investigating the properties of A-ring substituted nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-ones (nitroCBIs) as hypoxia-activated prodrugs for antitumor therapy.
    Tercel M; Yang S; Atwell GJ; Smith E; Gu Y; Anderson RF; Denny WA; Wilson WR; Pruijn FB
    Bioorg Med Chem; 2010 Jul; 18(14):4997-5006. PubMed ID: 20580559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
    Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
    Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
    Newman SP; Foster PA; Stengel C; Day JM; Ho YT; Judde JG; Lassalle M; Prevost G; Leese MP; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2008 Jan; 14(2):597-606. PubMed ID: 18223236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
    Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
    Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I.
    Kamiya D; Uchihata Y; Ichikawa E; Kato K; Umezawa K
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1111-4. PubMed ID: 15686923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agents.
    Tercel M; Atwell GJ; Yang S; Stevenson RJ; Botting KJ; Boyd M; Smith E; Anderson RF; Denny WA; Wilson WR; Pruijn FB
    J Med Chem; 2009 Nov; 52(22):7258-72. PubMed ID: 19877646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
    Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.